2Wu Gu&ngqi.Olinical observ&tion of 56 cases of mitox&ntrone &nd cyt&r&bine in treatment of &cute promyelocytic leukemi&[J].Ohin& Journ&l of industrial medicine,200i,4(6):458-459.
6Li Jing,MA &nd HDA regimen in the treatment of &cute myeloid lekemi& to compare the short-term cr&tive effects[J].Anhui medic&l journal, 2005,24(6): 57-58.
9Thress K,Song J,Iormoto Ri,et al.Reversible inhibition of HSP70 chaperone function by scythe and reaper[J].EMBO J,2001,20(5):1033-1041.
10Lowenberg B,Suciu S,Archimbaud E,et al.Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy-the value of low-dose cytarabine for maintenance of remission,and an assessment of prognostic factors in acute myeloid leukemia in the elderly:final report[J].J Clin Oncol,1998,16(3):872.